GPI W2
Pill imprint GPI W2 has been identified as Senna 8.6 mg.
Senna is used in the treatment of constipation; bowel preparation and belongs to the drug class laxatives. Risk cannot be ruled out during pregnancy.
Senna 8.6 mg is not subject to the Controlled Substances Act.
See also related documents.
Senna Images
- Imprint:
-
GPI W2
- Strength:
- 8.6 mg
- Color:
- Brown
- Availability:
- Rx and/or OTC
- Drug Class:
- Laxatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Cypress Pharmaceutical Inc
- National Drug Code (NDC):
- 60258-0950
More Senna resources
- Evac-u-gen Chewable Tablets (Wolters Kluwer)
- Senna-Lax (Wolters Kluwer)
- Sennosides (Wolters Kluwer)
- Sennosides Chewable Tablets (Wolters Kluwer)
- Sennosides Granules (Wolters Kluwer)
- Sennosides Liquid (Wolters Kluwer)
- Senna Smooth (Cerner Multum)
- Senna Soft (Cerner Multum)
- Sennalax (Cerner Multum)
- senna (Cerner Multum)
- Senna (AHFS DI)
- Senna (Wolters Kluwer)
- Sennagen (FDA)
- Senna (Wolters Kluwer)
- Senna (Wolters Kluwer)


